Navigation Links
Discovery of key protein's shape could lead to improved bacterial pneumonia vaccine

Scientists at St. Jude Children's Research Hospital have discovered that the shape of a protein on the surface of pneumonia bacteria helps these germs invade the human bloodstream. This finding, published Dec. 16 online by the EMBO Journal, could help scientists develop a vaccine that is significantly more effective at protecting children against the disease. The St. Jude researchers determined the shape of a large, paddle-like molecule that Streptococcus pneumoniae bacteria use to latch onto cells lining the throat and lungs. The protein, called CbpA, binds to a molecule on the cell called pIgR, which takes antibodies from the bloodstream on one side of the cell and transports them to the other side. There it releases the antibody at the lining of the throat and lungs. If a pneumococcus bacterium is hovering on the lining of the respiratory tract, this germ binds to pIgR and pushes this antibody shuttle back through the cell to the bloodstream. Once at the other side of the cell, the pneumococcus breaks free of pIgR and enters the blood, where it can multiply and infect the body.

S. pneumoniae is the only bacterium known to use CbpA to invade human cells by binding to pIgR, according to Richard W. Kriwacki, Ph.D., associate member of St. Jude Structural Biology. Kriwacki is senior author of the EMBO Journal report. “The fact that we now know the structure of this important protein means we can begin to develop a vaccine that is more effective in children than those that are currently available,?Kriwacki said. Elaine Tuomanen, M.D., chair of Infectious Diseases and director of the Children’s Infection Defense Center at St. Jude, is co-author of the EMBO Journal paper. “Using CbpA as the key part of a new vaccine against S. pneumoniae would solve a problem that now hinders our ability to protect children from this infection,?Tuomanen said. Current pneumonia vaccines designed to protect adults against more than two dozen strains of S. pneumoniae do not work in
'"/>

Source:St. Jude Children's Research Hospital


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... played a vital role in China,s agricultural scene ... allowing growers to produce more varieties of vegetables, ... published report Chinese scientists called solar greenhouses "the ... crops in China." The team of researchers from ...
... LA JOLLA, Calif. March 17, 2011 Dr. Daniel ... Medicine Award for his "pioneering efforts" in sequencing, or spelling ... Von Hoff,s research and clinical work advances the art of ... all 3 billion letters of their DNA, to help determine ...
... 17, 2011Simulated interactions in which adults with autism converse ... social interaction skills, according to a novel study presented ... peer-reviewed journal published by Mary Ann Liebert, Inc. ( ... http://www.liebertpub.com/cyber More than half of individuals ...
Cached Biology News:Solar greenhouses: China's winning solution to global energy crisis 2Dr. Daniel Von Hoff presented with top genomics award from Scripps 2
(Date:12/19/2014)... The empty capsules market is ... population and technological innovations in the empty capsules ... catalysing the growth of the empty capsules market. ... , Scope of Report , The report will ... entrants/smaller firms to gauge the pulse of the ...
(Date:12/19/2014)... N.Y. , Dec. 18, 2014 Egenix, Inc. ... has been elected Chairman of the Board, to succeed ... and CEO, but will continue as a member of the ... he has added to the company over almost twenty years, ... The Board of Directors has established a Search Committee ...
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... 2014 Achim Noack has been named ... Group. In this position, Noack will assist Jerry Stoller, ... develop marketing strategy and supervise global marketing management and ... has tremendous knowledge and experience in the crop protection ... experience and innovative thinking will be a great asset ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... frequently,relapsing bipolar disorder had a significant delay in ... injection (RLAI) was combined,with standard treatment, according to ... RLAI and standard treatment to those who received,standard ... presented yesterday at the 14th Biennial Winter Workshop,on ...
... BioSciences, Inc. today,announced that the Company will present ... Dana Point, CA on Tuesday, February 19, 2008 ... live web cast of the presentation at, http://www.darabiosciences.com ... available at,the same location., About DARA BioSciences, ...
... 4 Amarin Corporation plc,(NASDAQ: AMRND ) ... established,the position of Lead Independent Director and has ... role. In his capacity as Lead,Independent Director, Dr. ... the independent directors, and will preside over those ...
Cached Biology Technology:Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 3Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 4Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 5DARA BioSciences to Present at the ROTH Growth Stock Conference 2Amarin Appoints Dr. William Mason as Lead Independent Director 2Amarin Appoints Dr. William Mason as Lead Independent Director 3
...
...
...
... kits are designed to rapidly and reliably ... patented APA Technology. APAgene provides hassle-free, ready-to ... All necessary ingredients are provided in each ... used for gap filling, localized cloning of ...
Biology Products: